Granted Patent
Utility
US 5,670,150 · App. 08/436,843
Non-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM)
Inventors:
Anne Cooke, Herman Waldmann
Patented Case
View Patent ↗
Granted: Sep 23, 1997
Filed: May 8, 1995
Inventors
Anne Cooke
Herman Waldmann
Assignees (at issue)
University College London
Glaxo Wellcome P.L.C.
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.